Prevention and treatment of amyloidogenic diseases

Details Prevention and treatment of amyloidogenic diseases Prevention and treatment of amyloidogenic diseases

2011-07-12

2011-07-12

Kolker, Daniel E (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07977316

ABSTRACT:
Disclosed are pharmaceutical compositions and methods for preventing or treating a number of amyloid diseases, including Alzheimer's disease, prion diseases, familial amyloid neuropathies and the like. The pharmaceutical compositions include immunologically reactive amounts of amyloid fibril components, particularly fibril-forming peptides or proteins. Also disclosed are therapeutic compositions and methods which use immune reagents that react with such fibril components.

REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
patent: 4883666 (1989-11-01), Sabel et al.
patent: 5004697 (1991-04-01), Pardridge
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5187153 (1993-02-01), Cordell et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5220013 (1993-06-01), Ponte et al.
patent: 5231000 (1993-07-01), Majocha et al.
patent: 5231170 (1993-07-01), Averback
patent: 5262303 (1993-11-01), Sipe et al.
patent: 5266561 (1993-11-01), Cooper et al.
patent: 5270165 (1993-12-01), Van Nostrand et al.
patent: 5290762 (1994-03-01), Lezdey et al.
patent: 5387742 (1995-02-01), Cordell
patent: 5434170 (1995-07-01), Andrulis, Jr.
patent: 5441870 (1995-08-01), Seubert et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5571499 (1996-11-01), Hafler et al.
patent: 5571500 (1996-11-01), Hafler et al.
patent: 5583112 (1996-12-01), Kensil et al.
patent: 5585100 (1996-12-01), Mond et al.
patent: 5593846 (1997-01-01), Schenk et al.
patent: 5605811 (1997-02-01), Seubert et al.
patent: 5612486 (1997-03-01), McConlogue et al.
patent: 5622701 (1997-04-01), Berg
patent: 5641473 (1997-06-01), Hafler et al.
patent: 5641474 (1997-06-01), Hafler et al.
patent: 5643562 (1997-07-01), Kisilevsky et al.
patent: 5645820 (1997-07-01), Hafler et al.
patent: 5679348 (1997-10-01), Nesburn et al.
patent: 5688651 (1997-11-01), Solomon
patent: 5733547 (1998-03-01), Weiner et al.
patent: 5736142 (1998-04-01), Sette et al.
patent: 5744368 (1998-04-01), Goldgaber et al.
patent: 5750349 (1998-05-01), Suzuki et al.
patent: 5750361 (1998-05-01), Prusiner et al.
patent: 5753624 (1998-05-01), McMichael et al.
patent: 5773007 (1998-06-01), Penney et al.
patent: 5776468 (1998-07-01), Hauser et al.
patent: 5780587 (1998-07-01), Potter
patent: 5786180 (1998-07-01), Konig et al.
patent: 5824322 (1998-10-01), Balasubramanian
patent: 5837473 (1998-11-01), Maggio et al.
patent: 5837672 (1998-11-01), Schenk et al.
patent: 5846533 (1998-12-01), Prusiner
patent: 5849298 (1998-12-01), Weiner et al.
patent: 5851996 (1998-12-01), Kline
patent: 5854204 (1998-12-01), Findeis et al.
patent: 5854996 (1998-12-01), Kline
patent: 5866124 (1999-02-01), Hardman et al.
patent: 5869054 (1999-02-01), Weiner et al.
patent: 5869093 (1999-02-01), Weiner et al.
patent: 5877399 (1999-03-01), Hsiao et al.
patent: 5935927 (1999-08-01), Vitek et al.
patent: 5948763 (1999-09-01), Soto-Jara et al.
patent: 5955079 (1999-09-01), Mond et al.
patent: 5955317 (1999-09-01), Suzuki et al.
patent: 5958883 (1999-09-01), Snow
patent: 5972269 (1999-10-01), Barros et al.
patent: 5972369 (1999-10-01), Roorda et al.
patent: 5989566 (1999-11-01), Cobb et al.
patent: 6057367 (2000-05-01), Stamler et al.
patent: 6114133 (2000-09-01), Seubert et al.
patent: 6150091 (2000-11-01), Pandolfo et al.
patent: 6262335 (2001-07-01), Hsiao et al.
patent: 6284221 (2001-09-01), Schenk et al.
patent: 6294171 (2001-09-01), McMichael
patent: 6417178 (2002-07-01), Klunk et al.
patent: 6923964 (2005-08-01), Schenk
patent: 2001/0018053 (2001-08-01), McMichael
patent: 2001/0021769 (2001-09-01), Prusiner
patent: 2002/0009445 (2002-01-01), Du et al.
patent: 2002/0077288 (2002-06-01), Frangione
patent: 2002/0102261 (2002-08-01), Raso
patent: 2002/0132268 (2002-09-01), Chang et al.
patent: 2002/0136718 (2002-09-01), Raso
patent: 2002/0162129 (2002-10-01), Lannfeit
patent: 2002/0168377 (2002-11-01), Schaetzl
patent: 2002/0197258 (2002-12-01), Ghanbari et al.
patent: 2003/0147882 (2003-08-01), Solomon et al.
patent: 451 700 (1991-10-01), None
patent: 276 723 (1993-12-01), None
patent: 613 007 (1994-08-01), None
patent: 666 080 (1995-08-01), None
patent: 359 783 (1995-11-01), None
patent: 683 234 (1995-11-01), None
patent: 440 619 (1996-01-01), None
patent: 526 511 (1997-05-01), None
patent: 782 859 (1997-07-01), None
patent: 783 104 (1997-07-01), None
patent: 594 607 (1997-08-01), None
patent: 845 270 (1998-06-01), None
patent: 863 211 (1998-09-01), None
patent: 868 918 (1998-10-01), None
patent: 0872558 (1998-10-01), None
patent: 652 962 (1998-12-01), None
patent: 911 036 (1999-04-01), None
patent: 561 087 (1999-08-01), None
patent: 639 081 (1999-11-01), None
patent: 506 785 (2000-03-01), None
patent: 1 172 378 (2002-01-01), None
patent: 2 220 211 (1990-01-01), None
patent: 2 335 192 (1999-09-01), None
patent: 88/10120 (1988-12-01), None
patent: 89/01343 (1989-02-01), None
patent: 89/03687 (1989-05-01), None
patent: 89/06242 (1989-07-01), None
patent: 89/06689 (1989-07-01), None
patent: 90/12870 (1990-11-01), None
patent: 90/12871 (1990-11-01), None
patent: 91/08760 (1991-06-01), None
patent: 91/12816 (1991-09-01), None
patent: 91/16819 (1991-11-01), None
patent: 91/16819 (1991-11-01), None
patent: 91/19810 (1991-12-01), None
patent: 92/06187 (1992-04-01), None
patent: 92/06708 (1992-04-01), None
patent: 92/13069 (1992-08-01), None
patent: 93/02189 (1993-02-01), None
patent: 93/04194 (1993-03-01), None
patent: 93/14200 (1993-07-01), None
patent: 93/15760 (1993-08-01), None
patent: 93/16724 (1993-09-01), None
patent: 93/21950 (1993-11-01), None
patent: 94/01772 (1994-01-01), None
patent: 94/03615 (1994-02-01), None
patent: 94/28412 (1994-12-01), None
patent: 95/04151 (1995-02-01), None
patent: 95/05853 (1995-03-01), None
patent: 95/11008 (1995-04-01), None
patent: 95/11311 (1995-04-01), None
patent: 95/11994 (1995-05-01), None
patent: 95/12815 (1995-05-01), None
patent: 95/31996 (1995-11-01), None
patent: 96/18900 (1996-06-01), None
patent: 96/25435 (1996-08-01), None
patent: 96/28471 (1996-09-01), None
patent: 96/39176 (1996-12-01), None
patent: WO 97/04317 (1997-02-01), None
patent: 97/10505 (1997-04-01), None
patent: 97/17613 (1997-05-01), None
patent: 97/21728 (1997-06-01), None
patent: 98/07850 (1998-02-01), None
patent: 98/44955 (1998-10-01), None
patent: 99/00150 (1999-01-01), None
patent: 99/06066 (1999-02-01), None
patent: 99/06545 (1999-02-01), None
patent: 99/27911 (1999-06-01), None
patent: 99/27944 (1999-06-01), None
patent: 99/27949 (1999-06-01), None
patent: 99/06545 (1999-11-01), None
patent: 99/58564 (1999-11-01), None
patent: 99/60021 (1999-11-01), None
patent: 99/60024 (1999-11-01), None
patent: 01/62284 (2000-03-01), None
patent: 00/43039 (2000-07-01), None
patent: 00/43049 (2000-07-01), None
patent: 00/72870 (2000-12-01), None
patent: 00/72876 (2000-12-01), None
patent: 00/72876 (2000-12-01), None
patent: 00/72880 (2000-12-01), None
patent: 00/72880 (2000-12-01), None
patent: 00/77178 (2000-12-01), None
patent: 02/03911 (2001-04-01), None
patent: 01/39796 (2001-06-01), None
patent: 01/42306 (2001-06-01), None
patent: 01/62801 (2001-08-01), None
patent: 01/77167 (2001-10-01), None
patent: 01/90182 (2001-11-01), None
patent: 02/34777 (2002-05-01), None
patent: 02/34878 (2002-05-01), None
patent: WO 2006/077442 (2006-07-01), None
Strachan 1989 (Biochem J. 263:365-3700.
Booth 1998 (Amyloid: Int J Exp Clin Invest 5:262-265).
Holmes 2008 (The Lancet 372:216-223).
“Anti-Inflammatory Drugs May Impede Alzheimer's,”New York Times National, Feb. 20, 1994.
Aguzzi et al., “Prion research: the next frontiers,”Nature, 1997, 398: 795-798.
Andersen et al., “Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?,”Neurology, 1995, 45: 1441-1445.
Associated Press, “Immune cells may promote Alzehimer's, a study finds,”The Boston Globe, Apr. 13, 1995.
Bard et al., “Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease,”Nature Medicine, 2000, 6(8):

Affiliated with

Also associated with

Rating

Prevention and treatment of amyloidogenic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention and treatment of amyloidogenic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of amyloidogenic diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2637276